Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview
Worldwide, more than 1.2 million adolescents and young adults (AYAs; those aged 15–39 years) are diagnosed with cancer each year. Although considerable variability exists according to cancer site and stage of disease, the 5-year relative survival at the time of diagnosis has been estimated at >80...
Gespeichert in:
Veröffentlicht in: | Cancers 2021-09, Vol.13 (19), p.4847 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 19 |
container_start_page | 4847 |
container_title | Cancers |
container_volume | 13 |
creator | Janssen, Silvie H. M. van der Graaf, Winette T. A. van der Meer, Daniël J. Manten-Horst, Eveliene Husson, Olga |
description | Worldwide, more than 1.2 million adolescents and young adults (AYAs; those aged 15–39 years) are diagnosed with cancer each year. Although considerable variability exists according to cancer site and stage of disease, the 5-year relative survival at the time of diagnosis has been estimated at >80% for all AYA patients with cancer combined. Extensive survivorship research in recent decades has focused on patients diagnosed with cancer as children (39 years), yet few studies to date have reported outcomes specifically for patients diagnosed as AYAs. With increasing incidence and improving survival for many tumor types, leading to the majority of AYA patients with cancer becoming long-term survivors, there is a critical need for research efforts to inform the survivorship care of this growing population. This article describes the population of AYA cancer survivors according to their epidemiology and late and long-term effects, the challenges and models of AYA survivorship care, as well as future opportunities for research and healthcare. |
doi_str_mv | 10.3390/cancers13194847 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508173</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2581799376</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-9f127e49e6844f24ef24cf4092f077f752a62f9608690882c61546766b07fbb73</originalsourceid><addsrcrecordid>eNpdkUtLAzEQx4MotqhnrwEv9VCbTbJ5eBCW4gsFBfXQU0jTpN2y3dRkd8Vvb6pFtAPDDMyP_7wAOM3QBSESjYyujQ0xI5mkgvI90MeI4yFjku7_yXvgJMYlSkZIxhk_BD1CGRGE4D54KGa-stHYuoG6nsGJb-s5LGZt1cBBMSnO4fi7C3xpQ1d2PsRFuYbPQZumNDZewqKGT51NNftxDA6crqI92cYj8HZz_Tq-Gz4-3d6Pi8ehIVI0Q-kyzC2VlglKHaY2uXEUSewQ547nWDPsJEOCSSQENizLKeOMTRF30yknR-DqR3fdTld2tpk96EqtQ7nS4VN5Xar_lbpcqLnvlMiRyDhJAoOtQPDvrY2NWpXpBFWla-vbqHCeMCkJZwk920GXvg11Wm9DIck5z0WiRj-UCT7GYN3vMBlSm1-pnV-RL8VPhTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580977758</pqid></control><display><type>article</type><title>Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Janssen, Silvie H. M. ; van der Graaf, Winette T. A. ; van der Meer, Daniël J. ; Manten-Horst, Eveliene ; Husson, Olga</creator><creatorcontrib>Janssen, Silvie H. M. ; van der Graaf, Winette T. A. ; van der Meer, Daniël J. ; Manten-Horst, Eveliene ; Husson, Olga</creatorcontrib><description>Worldwide, more than 1.2 million adolescents and young adults (AYAs; those aged 15–39 years) are diagnosed with cancer each year. Although considerable variability exists according to cancer site and stage of disease, the 5-year relative survival at the time of diagnosis has been estimated at >80% for all AYA patients with cancer combined. Extensive survivorship research in recent decades has focused on patients diagnosed with cancer as children (<15 years) and older adults (>39 years), yet few studies to date have reported outcomes specifically for patients diagnosed as AYAs. With increasing incidence and improving survival for many tumor types, leading to the majority of AYA patients with cancer becoming long-term survivors, there is a critical need for research efforts to inform the survivorship care of this growing population. This article describes the population of AYA cancer survivors according to their epidemiology and late and long-term effects, the challenges and models of AYA survivorship care, as well as future opportunities for research and healthcare.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13194847</identifier><identifier>PMID: 34638332</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Age groups ; Biology ; Brain cancer ; Cancer ; Cancer therapies ; Cardiovascular disease ; Chemotherapy ; Colorectal cancer ; Epidemiology ; Health care ; Life expectancy ; Long-term effects ; Lymphoma ; Medical diagnosis ; Medical prognosis ; Melanoma ; Mortality ; Patients ; Pediatrics ; Radiation therapy ; Review ; Surveillance ; Survival ; Testicular cancer ; Tumors ; Young adults</subject><ispartof>Cancers, 2021-09, Vol.13 (19), p.4847</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-9f127e49e6844f24ef24cf4092f077f752a62f9608690882c61546766b07fbb73</citedby><cites>FETCH-LOGICAL-c398t-9f127e49e6844f24ef24cf4092f077f752a62f9608690882c61546766b07fbb73</cites><orcidid>0000-0002-3297-3734 ; 0000-0001-7549-3338 ; 0000-0003-1406-1739 ; 0000-0002-1387-8686</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508173/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508173/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Janssen, Silvie H. M.</creatorcontrib><creatorcontrib>van der Graaf, Winette T. A.</creatorcontrib><creatorcontrib>van der Meer, Daniël J.</creatorcontrib><creatorcontrib>Manten-Horst, Eveliene</creatorcontrib><creatorcontrib>Husson, Olga</creatorcontrib><title>Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview</title><title>Cancers</title><description>Worldwide, more than 1.2 million adolescents and young adults (AYAs; those aged 15–39 years) are diagnosed with cancer each year. Although considerable variability exists according to cancer site and stage of disease, the 5-year relative survival at the time of diagnosis has been estimated at >80% for all AYA patients with cancer combined. Extensive survivorship research in recent decades has focused on patients diagnosed with cancer as children (<15 years) and older adults (>39 years), yet few studies to date have reported outcomes specifically for patients diagnosed as AYAs. With increasing incidence and improving survival for many tumor types, leading to the majority of AYA patients with cancer becoming long-term survivors, there is a critical need for research efforts to inform the survivorship care of this growing population. This article describes the population of AYA cancer survivors according to their epidemiology and late and long-term effects, the challenges and models of AYA survivorship care, as well as future opportunities for research and healthcare.</description><subject>Age groups</subject><subject>Biology</subject><subject>Brain cancer</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cardiovascular disease</subject><subject>Chemotherapy</subject><subject>Colorectal cancer</subject><subject>Epidemiology</subject><subject>Health care</subject><subject>Life expectancy</subject><subject>Long-term effects</subject><subject>Lymphoma</subject><subject>Medical diagnosis</subject><subject>Medical prognosis</subject><subject>Melanoma</subject><subject>Mortality</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Radiation therapy</subject><subject>Review</subject><subject>Surveillance</subject><subject>Survival</subject><subject>Testicular cancer</subject><subject>Tumors</subject><subject>Young adults</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkUtLAzEQx4MotqhnrwEv9VCbTbJ5eBCW4gsFBfXQU0jTpN2y3dRkd8Vvb6pFtAPDDMyP_7wAOM3QBSESjYyujQ0xI5mkgvI90MeI4yFjku7_yXvgJMYlSkZIxhk_BD1CGRGE4D54KGa-stHYuoG6nsGJb-s5LGZt1cBBMSnO4fi7C3xpQ1d2PsRFuYbPQZumNDZewqKGT51NNftxDA6crqI92cYj8HZz_Tq-Gz4-3d6Pi8ehIVI0Q-kyzC2VlglKHaY2uXEUSewQ547nWDPsJEOCSSQENizLKeOMTRF30yknR-DqR3fdTld2tpk96EqtQ7nS4VN5Xar_lbpcqLnvlMiRyDhJAoOtQPDvrY2NWpXpBFWla-vbqHCeMCkJZwk920GXvg11Wm9DIck5z0WiRj-UCT7GYN3vMBlSm1-pnV-RL8VPhTA</recordid><startdate>20210928</startdate><enddate>20210928</enddate><creator>Janssen, Silvie H. M.</creator><creator>van der Graaf, Winette T. A.</creator><creator>van der Meer, Daniël J.</creator><creator>Manten-Horst, Eveliene</creator><creator>Husson, Olga</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3297-3734</orcidid><orcidid>https://orcid.org/0000-0001-7549-3338</orcidid><orcidid>https://orcid.org/0000-0003-1406-1739</orcidid><orcidid>https://orcid.org/0000-0002-1387-8686</orcidid></search><sort><creationdate>20210928</creationdate><title>Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview</title><author>Janssen, Silvie H. M. ; van der Graaf, Winette T. A. ; van der Meer, Daniël J. ; Manten-Horst, Eveliene ; Husson, Olga</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-9f127e49e6844f24ef24cf4092f077f752a62f9608690882c61546766b07fbb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age groups</topic><topic>Biology</topic><topic>Brain cancer</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cardiovascular disease</topic><topic>Chemotherapy</topic><topic>Colorectal cancer</topic><topic>Epidemiology</topic><topic>Health care</topic><topic>Life expectancy</topic><topic>Long-term effects</topic><topic>Lymphoma</topic><topic>Medical diagnosis</topic><topic>Medical prognosis</topic><topic>Melanoma</topic><topic>Mortality</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Radiation therapy</topic><topic>Review</topic><topic>Surveillance</topic><topic>Survival</topic><topic>Testicular cancer</topic><topic>Tumors</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janssen, Silvie H. M.</creatorcontrib><creatorcontrib>van der Graaf, Winette T. A.</creatorcontrib><creatorcontrib>van der Meer, Daniël J.</creatorcontrib><creatorcontrib>Manten-Horst, Eveliene</creatorcontrib><creatorcontrib>Husson, Olga</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janssen, Silvie H. M.</au><au>van der Graaf, Winette T. A.</au><au>van der Meer, Daniël J.</au><au>Manten-Horst, Eveliene</au><au>Husson, Olga</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview</atitle><jtitle>Cancers</jtitle><date>2021-09-28</date><risdate>2021</risdate><volume>13</volume><issue>19</issue><spage>4847</spage><pages>4847-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Worldwide, more than 1.2 million adolescents and young adults (AYAs; those aged 15–39 years) are diagnosed with cancer each year. Although considerable variability exists according to cancer site and stage of disease, the 5-year relative survival at the time of diagnosis has been estimated at >80% for all AYA patients with cancer combined. Extensive survivorship research in recent decades has focused on patients diagnosed with cancer as children (<15 years) and older adults (>39 years), yet few studies to date have reported outcomes specifically for patients diagnosed as AYAs. With increasing incidence and improving survival for many tumor types, leading to the majority of AYA patients with cancer becoming long-term survivors, there is a critical need for research efforts to inform the survivorship care of this growing population. This article describes the population of AYA cancer survivors according to their epidemiology and late and long-term effects, the challenges and models of AYA survivorship care, as well as future opportunities for research and healthcare.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34638332</pmid><doi>10.3390/cancers13194847</doi><orcidid>https://orcid.org/0000-0002-3297-3734</orcidid><orcidid>https://orcid.org/0000-0001-7549-3338</orcidid><orcidid>https://orcid.org/0000-0003-1406-1739</orcidid><orcidid>https://orcid.org/0000-0002-1387-8686</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2021-09, Vol.13 (19), p.4847 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508173 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
subjects | Age groups Biology Brain cancer Cancer Cancer therapies Cardiovascular disease Chemotherapy Colorectal cancer Epidemiology Health care Life expectancy Long-term effects Lymphoma Medical diagnosis Medical prognosis Melanoma Mortality Patients Pediatrics Radiation therapy Review Surveillance Survival Testicular cancer Tumors Young adults |
title | Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T19%3A17%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adolescent%20and%20Young%20Adult%20(AYA)%20Cancer%20Survivorship%20Practices:%20An%20Overview&rft.jtitle=Cancers&rft.au=Janssen,%20Silvie%20H.%20M.&rft.date=2021-09-28&rft.volume=13&rft.issue=19&rft.spage=4847&rft.pages=4847-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13194847&rft_dat=%3Cproquest_pubme%3E2581799376%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2580977758&rft_id=info:pmid/34638332&rfr_iscdi=true |